PUMA BIOTECHNOLOGY, INC. (PBYI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $02011: $53.38M2012: $137.41M2013: $43.04M2014: $38.54M2015: $31.57M2016: $194.49M2017: $81.70M2018: $108.42M2019: $60.04M2020: $85.29M2021: $63.13M2022: $76.20M2023: $84.58M2024: $69.22M2025: $29.64M$29.64M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$29.64M-57.2%
2024$69.22M-18.2%
2023$84.58M+11.0%
2022$76.20M+20.7%
2021$63.13M-26.0%
2020$85.29M+42.1%
2019$60.04M-44.6%
2018$108.42M+32.7%
2017$81.70M-58.0%
2016$194.49M+516.1%
2015$31.57M-18.1%
2014$38.54M-10.5%
2013$43.04M-68.7%
2012$137.41M+157.4%
2011$53.38M
2010$0